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Chronic Liver Allograft Rejection and Obliterative Arteriopathy: 
Possible Pathogeneic Mechanisms 
S. Oguma,' T. Zerbe,' B. Banner,' S. Belle,2 T.E. Starzl,3 and A.J. Demetris' 
CHRONIC REJECTION is a major cause of late liver 
allograft failure. Generally accepted pathologic fea-
tures of this condition include chronic obliterative arteriopa-
thy (COA) and bile duct loss. The mechanisms involved in 
graft damage are poorly understood. 
Bile duct loss has been attributed to direct Iymphocyto-
toxic attack, which seems reasonable considering the histo-
logic appearance of rejection. However, ischemia due to 
COA has been largely overlooked as a cofactor in the 
pathogenesis of bile duct loss. It is known that the hepatic 
artery is the only blood supply to the intra-hepatic biliary 
tree. 
In this study, we studied the effect of ischemia. on bile duct 
loss by studying the relationship between the degree of COA 
and intensity of bile duct loss. Furthermore, in order to get a 
greater understanding of the pathogenesis of COA. we 
analyzed the lineage of cells comprising COA lesion in heart. 
liver and kidney allografts. Special attention was focused on 
detecting cells with phenotypic characteristics of dendritic 
cell (DC) lineage. DC playa pivotal role in the initiation of 
immunological reactions. 
MATERIALS AND METHODS 
Source of Matenals and Selection of Cases 
Liver allografts ,.hich failed because of chronic rejection ,.ere 
reviewed E~ - 28). The diagnOSIs of chroniC rejection was based on 
a charactenstlc chnical course and confirmed b~ histologic analysis 
of the remo'Cd allografts. ~ormalliyDers "'ere selected from autopsy 
cases In ,.hich there \Oias no clinical or pathological evidence of hver 
disease. 
Tissue sampling for histologic sections from the failed allografts 
and control livers was performed according to a predefined protocol. 
Three scctlons "ere taken from the hilum. two sectIOns from the left 
lobe. and three seCllons from the right lobe' 
The three secllons taken from the hilum of each liver ,.ere 
examined blindly and mdependently by two of the authors for the 
degree of narrowing of hepatic arterial branches and the percentage 
of vessels affected. If greater than 70'k of the arteries demonstrated 
more than 75'1, stenosIs. the case was labeled as "severe COA". 
Conversely. In "mild COA". greater than 70'1 of arteries sho\Oied 
less than 35% narro,.mg (n - 10) The intermediate cases (n - 10) 
were excluded 10 accentuate any possible differences between the 
two extreme groups. v.hich may result In recognition of the role o( 
Ischemia 10 bile duct loss. General patient data is shown in Table I. 
The average age of allograft patients \Oiith mild COA was 31.9 
years compared to 12.6 (or the patients with severe COA (P > 0.05). 
The average graft survival was much shorter in those with severe 
COA (7.7 months) compared to those with mild COA (33.7 months) 
(P < OOS). Complete MHC typing of both donor and recipient was 
available in only 8 of the 18 cases analyzed. No particular trend \Oias 
noted in this small sample. All patients were maintained on baseline 
immunosuppression of cyclosporine and steroids. Episodes of acute 
cellular rejection were treated with a steroid bolus or recycling doses. 
If steroids were unsuccessful. OKT3 (Ortho pharmoceuticals. Rari-
tan. NJ) was used. 
Histometrical Study for Arterial Loss 
The presence or absence of any artery within the confines of the 
portal tract and the size of the only or largest artery in the portal 
tract was recorded. This assessment was repeated for all portal tracts 
in every section of the selected cases (average 200-300 portal 
tracls/case). The size of the artery was determined by measuring the 
shortest diameter of the vessel to the outer e:ll.lent of the media using 
an ocular micrometer. The percentage of portal tracts \Oiith arteries 
and the size distribution of the only or largest artery was calculated 
according to a predefined range of arterial diameter «35. 35-54. 
55-74. ~ 75 microns). 
Histometrical Study for Bile Duct Loss 
An analysis similar to that done by Nakanuma was also performed 
to determine the extent of duct loss and size of vanished ducts.1 In 
brief. it is kno\Oin that arteries and bile ducts of a similar diameter 
occur in parallel in the portal tracts of the normal liver. Precise 
measurement of the diameter of the only or largest artery in each 
portal tract was recorded as described above. Tracing an imaginary 
circle 3 times the recorded arterial diameter from the external media 
of the vessel, circumscribed the area in which the only or largest 
accompanying bile duct should be detected. The presence or absence 
of a bile duct within this area was then recorded for each portaltraet 
of every section. The result was labeled according to the predefined 
range of artenal diameter for each liver and expressed as the rate of 
bile duct artery (BD-A) parallelism. It must be noted that the rate of 
parallelism was determined onl~ for those portal tracts which 
contained arteries. Portallracts .. ithout arteries and bile ducts were 
e;t;c1uded from the determinations of BD-A parallelism. 
Study of Chronic Obliterative Vasculopathy (COA) 
Heart (n - 7), kidney (n - 9) and liver (n - 7) allografts which 
failed from chronic rejection .. ere reviewed. Formalin fixed and 
paraffin embedded blocks "'ere CUI at 4 microns and routinely 
stained with hematoxylin and eosin. Masson's trichrome and Ver-
hoff/Van Gieson for clastic tissue. Paraffin embedded sections were 
also subjected to staining \Oiith various antibodIes using the avidin-
biotin-<omplex (ABC) method. 
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Table 1. Demographic Data and Original Hepatic Disease 
Grall 
Survival Age Original Hapalie O,sea •• 
C.ses (months) Sex PSC CAH HCC SMN PSC AAO OIC 
Mild 
(n - 10) 1.3·140.5 14-47 4 3 o o 
(33.7) (31.9) 
F:M - 8:2 
Severe 
(n - 8) 2.0·170 2·32 o o 2 2 2 
(7.7) ( 12.6) 
F:M - 2:6 
PBe - Primary Biliary Cirrhosis. CAH - Chronic Active Hepatitis (Non A. Non B). HCC - Hepatocellular Carcinoma. SMN - Submassive 
Necrosis. PSC - Primary Sclerosing Cholangitis. AAD - Alpha· I-Antitrypsin Deficiency. 01 C - Other I Congenital. 
Antibodies for lysozyme. SIOO protein and T-Iymphocytes 
(UCHL-l, DAKO. Santa Barbara. CAl and for actin (Biogenex. 
San Ramon. CAl were used. ImmunoAuorescent staining was also 
performed on frozen tissue embedded in OCT compound using a 
simple indirect technique with appropriate Auoresceinated second-
ary antibodies. Primary antibodies included HLA-DR and Leu 4 
(CD3) (Becton Dickinson. Mountain View. CAl. 
RESULTS 
Analysis 01 Bile Duct Loss in Chronic liver Rejection 
Distribution and Si:e of Portal Tract Arteries. The per-
centage of portal tracts containing arteries or arterioles were 
compared for each of the 14 subjects with no eOA (con-
trols), the 10 subjects with mild eOA and 8 subjects with 
severe eOA (Figure I). Overall. 90.9'1( of the portal tracts in 
controls. 61.3'1( of the portal tracts 10 cases with mild eOA 
and 25.3'1( of the portal tracts in cases with severe eOA had 
at least one artery. The logistic regression model was used to 
determine .... hether there was an association between severity 
of eOA and the presence of arteries in the portal tract J A 
statistically significant difference between each pair of 
groups was found. 
Figure 2 shows the percentage of portal tracts in which the 
largest or only artery was d5. 35-54. 55- 74.2: 75 microns in 
diameter for each subject classified by the degree of eOA. 
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Overall, the distribution of the size of the largest or only 
artery in portal tracts with at least one artery was signifi-
cantly (P < 0.001) different among groups, using the chi-
square test of association for independent samples. 
Pairwise comparison of the three groups using the same 
statistical technique demonstrated that the distribution of 
the size of the largest or only artery was significantly 
different (P < 0.00 I) between each pair. Among 81'1( of the 
portal tracts of controls. the largest or only artery was less 
than 35 microns, compared to about 58% of the portal tracts 
in cases with mild eOA and 41 q of the portal tracts in cases 
with severe e~AK At the other extreme. only 47r of the portal 
tracts in controls contained a single or largest Jrtery. 75 
microns or greater in diameter. ranging from 1.9<; to 7.9'1 
among the 14 subjects. Six percent of portal tracts in cases 
with mild eOA (range 3.1'"; to 12.6'1) and 14'"; of portal 
tracts in cases .... ith severe eOA (range 3.17, to 30.8r;) these 
differences are also statistically significant (P < 0.0011. 
Bile Duct-Arterial Parallelism. The mean rate of bile 
duct-artery (BD-A) parallelism versus arterial Sile. claSSI-
fied by the degree of eOA is shown in Figure 3. There IS a 
statistically significant (P < 0.001) trend toward decreaSing 
parallelism with decreasing arterial sile in both the mild and 
severe e~AK using a test for linear trend.' USing the chi-
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square test for independent samples. statistically significant 
differences (p < 0.01) for BD,A parallelism between groups 
(controls vs. mild COA. controls vs, severe COA. and mild 
COA vs. severe COAl were found in all size categories. 
except between controls and mild COA for arteries greater 
than or equal to 75 microns in diameter, 
It must be remembered that the rate of BO-A parallelism 
was determined using only those portal tracts which con-
tained artenes. Bile duct loss with associated artery loss was 
not specifically tabulated. Therefore. absolute bile duct loss. 
particularly involving the smaller ducts (<35 microns) is 
even greater than that expressed as a decrease in the rate of 
parallelism. 
Analysis of Chronic Oblilt!fali\e Arleriopath~D Light 
Microscopic Features of COA. \iany histopathologic fea-
tures were common to the affected arteries of all of the organ 
allografts. The vessels most severely affected by COA were 
those of medium size range. which were often the first and 
second order branching vessels of the particular arterial 
trees. 
The intima contained a varying degree of mononuclear 
innammation. subendothelial foam cells and apparent 
smooth muscle cell proliferation. Plasmacytic. neutrophilic 
and eosinophilic inflammation was less commonly present 
except in the cardiac allografts. The internal elastic lamina 
was often disrupted in arteries of kidney and heart allografts; 
in the liver it was mostly intact. 
The appearance of the media and periadventitial space 
was similar in all of the organs. The media was infiltrated to 
various degrees by macrophages, lymphocytes and foam 
cells. The inflammatory cells were located in areas of degen-
erating smooth muscle cells. Cuffs of periadventitial inflam' 
matory cells were seen around affected arteries. These 
periarterial cells appeared to invade into the media from 
without. as if the medial smooth muscle cells were the target 
of cellular mediated immunologic injury. Finally although 
we did not examine sequential biopsies. there appeared to be 
a temporal progression of the changes. Early lesions were 
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rich in inflammation and accompanied by smooth muscle cell 
proliferation. Thereafter. the inflammation gradually sub-
sided and the intima became sclerotic . 
Phenotypic Analysis by Immunohistology, Various 
admixtures of macrophages (lysozyme +) T-Iymphocytes 
(UCHL - J +). proliferating smooth muscle cells (actin +) 
and SIOO protein positive cells were seen in the thickened 
intima of involved vessels. The variation. to some extent. was 
dependent on the "age" of the lesion and organ. A detailed 
description of the findings present in each of the allograft 
organs is presented elsewhere. On closer examination. two 
types of intimal S I 00 + cells were seen. The first was round 
to oval with an oval. clef ted or angulated nucleus. These cells 
were uncommon. When present. they were located immedi-
ately subjacent to the endothelium. The second type of 
Sioo + cells was dendritic shaped and usually found in 
contact with nearby T-Iymphocytes and/or plasma cells; 
occasionally macrophages (Figure 4). The Sioo + dendritic 
cells were usually located deeper in the intima. near the 
internal elastic lamina. Likewise. activated and proliferating 
smooth muscle cells were seen in two locations. immediately 
subjacent to hypertrophied endothelial cells and deep intima. 
near the disrupted elastic lamina. Macrophages. T-Iympho-
cytes and rare S I 00 + dendritic cells were also seen in the 
media. 
The cuffs of inflammatory cells in the periadventitial 
space consisted predominantly of macrophages; T-Iympho-
cytes were less common. S I 00 + dendritic cells and/or 
terminal nerve twigs were the minority group. but were also 
easily recognized in the periadventitia. 
Serial frozen sections cut at 4 microns consecutively 
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stained for SIOO protein and HLA-DR were ex.amined. 
Round H LA-DR positive cells were seen in the intima. Other 
HLA-DR positive cells were spindle shaped. However. the 
morphologic resolution in the frozen section immunofluores-
cent stains were not of sufficient quality to separate smooth 
muscle cells from dendritic cells. Nevertheless. the elongated 
HLA-DR positive cells were in the same general location as 
the S I 00 + ones. 
DISCUSSION 
Analysis of the data reveals that quantifiable bile duct and 
small arterial loss are features of chronic liver allograft 
rejection. The degree of damage to both arteries and bile 
ducts increases as the size of each decreases. Additionally. 
the severity and size of arterial loss and vanished ducts is 
directly proportional to the degree of COA. 
Bile duct loss was recognized under two circumstances. 
One occurred when an artery without a corresponding bile 
duct was found. The other was recognized when there was 
loss of both the artery and the bile duct. Therefore. the 
results of this study offer indirect. but supportive evidence 
that two mechanisms may be responsible for bile duct loss: 
direct immunologic attack and ischemic injury. 
The absence of a bile duct when an artery is found is 
supporting evidence for a direct immunologic attack on the 
biliary epithelium. Other evidence also suggests that a 
primary immunologic insult to the biliary epithelium occurs. 
The histologic appearance of acute cellular rejection is 
characterized by lymphocytic invasion and evidence of 
degenerative changes in the biliary epithelium.'· Although 
biliary InflammatIOn is less severe in chronic rejection. 
careful light and electron microscopic examinations of livers 
undergOing chroniC rejection reveals lymphocytes in close 
contact with degenerating bile duct cells. lo 
The loss of ducts tn conjunction with arterial loss is 
indirect but suggestive eVidence that ischemic injury contrib-
utes to bile duct loss. We also found that the severity of duct 
loss and the size of the "vanished" ducts is directly propor-
tional to the degree of COA. Since the biliary tree in humans 
receives its blood supply exclusively from the hepatic arterial 
system. II .12 COA and peripheral arterial loss compromise 
blood flow to the dependent ducts. 
Two mechanisms may be responsible for small arterial loss 
in the portal tracts. Small portal arteries may be subject to 
ischemic necrosis because of more proximal vessel occlusion. 
The other possibility is that small portal arteries may be 
damaged by direct lymphocytic attack. Regardless of the 
mechanism. the result is the same: diminished blood flow to 
dependent bile ducts. I) 
The results of this study also offer some insight into the 
puzzling question of whether primary biliary cirrhosis recurs 
in liver allografts. Nakanuma also discovered that there was 
a decreased rate of BD-A parallelism for arteries 35-54. 
55-74 and 75-94 microns in PBC liver compared to controls.2 
In contrast. we found that the loss of bile ducts in the liver 
allografts was more restricted. Only those ducts with corre-
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sponding arteries less than 75 microns in diameter were 
missing. A decreased rate of BD-A parallelism for larger 
arteries was seen only when there was coexistant severe 
COA. However. all of the patients transplanted for PBC in 
this study fell into the group with mild COA. Therefore. none 
of the patients with PBC prior to transplantation who were 
included in this study demonstrated loss of larger ducts as 
shown by Nakanuma. Furthermore. larger excretory bile 
duct damage similar to that seen in sclerosing cholangitis is 
observed in liver allografts with COA but not in PBC. 
COA is not only a problem in liver. but all other solid 
organ aliografts. I .. 16 We therefore investigated the pheno-
typic characteristics of cells involved in COA lesions. The 
arteries affected by COA demonstrated a markedly thick-
ened intima. which contained activated smooth muscle cells. 
macrophages. T-Iymphocytes and S I 00 protein positive den-
dritic shaped cells (DCs). They were present when ongoing 
inAammatory destruction was occurring and became less 
frequent as the inAammation subsided and the organ 
assumed a "burned out" appearance. The detection of den-
dritic cells in the inAammed intima might be significant for 
understanding the development of COA. because they are 
efficient accessory cells. promoting T-Iymphocyte dependent 
immune reactions.I).11 
Information on the role of dendritic cells in the immune 
cascade is still limited. since they have only recently been 
studied to any extent. DCs are bone marrow deril'ed and 
constitute up to 0.5'( of peripheral blood mononuclear 
cells. 1911 They are extremely efficient accessory cells. nor-
mally express high density surface HLA-DR antigens and 
are potent stimulators of mixed lymphocyte reactions; 10-
100 times greater than macrophages in these respects.:::) 
DCs may also express complement receptors. but are unable 
to "process" particulate antigens because of the relative lack 
of endoplasmiC and lysolOmal activity.I •. :4 Therefore. DCs 
may associate with tYPical macrophages whose phagocytic 
and Iysozomal activities compensate for these relative defi-
ciencies. 
Once an effector cascade is directed against some anti-
gens. release of lymphoklOes and local production of leuko· 
trienes in the inAammed intima may induce smooth muscle 
cell proliferation and collagen deposition which might be 
ultimately responsible for luminal narrowing.1l When stimu-
lated. smooth muscle cells express class II antigens which 
may be a potential target for humoral and/or cellular 
immunological reactions.:· A very similar scenario may 
occur during the development of atherosclerosis 10 the gen-
eral population. 
Finally. these studies demonstrate that obliterative arte-
riopathy is a major problem in liver transplantation. similar 
to kidney and heart allografts.I'·ll Therefore. since early 
graft and patient survival has increased with advances in the 
field of transplantation. attention must be focused on eluci-
dating the pathogenesis of "graft atherosclerosis." A better 
understanding of this problem will permit the trial of novel. 
and perhaps effective therapy for this presently untreatable 
condition. 
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